Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis.

Kušić J, Kulić A, Djurković V, Marković R, Milačić V, Surić-Lambić L, Peković G.

Srp Arh Celok Lek. 2016 Nov-Dec;144(11-12):654-6.

PMID:
29659233
2.

Technical considerations for transabdominal aortic reconstruction with renal fusion and ectopia: case series.

Ilic NS, Koncar I, Dragas M, Cvetkovic S, Pejkic S, Kostic D, Milacic V, Davidovic L.

Vascular. 2010 Sep-Oct;18(5):269-74.

PMID:
20822721
3.
4.

Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and -independent processes.

Zhang X, Frezza M, Milacic V, Ronconi L, Fan Y, Bi C, Fregona D, Dou QP.

J Cell Biochem. 2010 Jan 1;109(1):162-172. doi: 10.1002/jcb.22394.

5.
6.

Metal complexes, their cellular targets and potential for cancer therapy.

Chen D, Milacic V, Frezza M, Dou QP.

Curr Pharm Des. 2009;15(7):777-91. Review.

PMID:
19275642
7.

Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells.

Cvek B, Milacic V, Taraba J, Dou QP.

J Med Chem. 2008 Oct 23;51(20):6256-8. doi: 10.1021/jm8007807. Epub 2008 Sep 25.

8.

Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.

Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP.

Cancer Res. 2008 Sep 15;68(18):7283-92. doi: 10.1158/0008-5472.CAN-07-6246.

9.
10.

Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.

Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP.

Curr Protein Pept Sci. 2008 Jun;9(3):227-39. Review.

11.

Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity.

Milacic V, Chen D, Giovagnini L, Diez A, Fregona D, Dou QP.

Toxicol Appl Pharmacol. 2008 Aug 15;231(1):24-33. doi: 10.1016/j.taap.2008.03.009. Epub 2008 Mar 28.

12.

Anti-tumor activity of N-thiolated beta-lactam antibiotics.

Chen D, Falsetti SC, Frezza M, Milacic V, Kazi A, Cui QC, Long TE, Turos E, Dou QP.

Cancer Lett. 2008 Sep 8;268(1):63-9. doi: 10.1016/j.canlet.2008.03.047. Epub 2008 May 12.

13.

Tea polyphenols, their biological effects and potential molecular targets.

Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C, Landis-Piwowar KR, Cui QC, Wali A, Chan TH, Dou QP.

Histol Histopathol. 2008 Apr;23(4):487-96. doi: 10.14670/HH-23.487. Review.

14.

Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues.

Yu Z, Wang F, Milacic V, Li X, Cui QC, Zhang B, Yan B, Dou QP.

Int J Mol Med. 2007 Dec;20(6):919-25.

PMID:
17982703
15.

Gold complexes as prospective metal-based anticancer drugs.

Milacic V, Fregona D, Dou QP.

Histol Histopathol. 2008 Jan;23(1):101-8. doi: 10.14670/HH-23.101. Review.

PMID:
17952862
16.

Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.

Chen D, Frezza M, Shakya R, Cui QC, Milacic V, Verani CN, Dou QP.

Cancer Res. 2007 Oct 1;67(19):9258-65.

17.

A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.

Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP.

Cancer Res. 2007 May 1;67(9):4303-10.

18.

The proteasome as a potential target for novel anticancer drugs and chemosensitizers.

Landis-Piwowar KR, Milacic V, Chen D, Yang H, Zhao Y, Chan TH, Yan B, Dou QP.

Drug Resist Updat. 2006 Dec;9(6):263-73. Epub 2007 Jan 2. Review.

PMID:
17197231
19.
20.

[Comatous states with special reference to coma of cerebrovascular etiology].

Milacić M, Kalezić P, Milacić V, Repac R.

Vojnosanit Pregl. 1975 May-Jun;32(3):329-31. Serbian. No abstract available.

PMID:
1146253

Supplemental Content

Loading ...
Support Center